Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.
Clinical Benefit
| Moderate |
Le service médical rendu par DICLOFENAC MIKA PHARMA 4% est modéré.
|
Clinical Added Value
| no clinical added value |
La spécialité Diclofénac Mika Pharma 4% n’apporte pas d’amélioration du service médical rendu (ASMR V) par rapport aux autres AINS topiques.
|
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
Pr4CnhqSGNYJSCTd
Listen
